386 related articles for article (PubMed ID: 16388207)
21. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
Stamatiou K; Alevizos A; Agapitos E; Sofras F
Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
[TBL] [Abstract][Full Text] [Related]
22. Basal cell hyperplasia in the peripheral zone of the prostate.
Thorson P; Swanson PE; Vollmer RT; Humphrey PA
Mod Pathol; 2003 Jun; 16(6):598-606. PubMed ID: 12808066
[TBL] [Abstract][Full Text] [Related]
23. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
[TBL] [Abstract][Full Text] [Related]
24. Autopsy study of prostatic weight and lesions in LUTH: a 12 month prospective study.
Erinomo OO; Anunobi CC; Orah NO
Nig Q J Hosp Med; 2013; 23(2):85-9. PubMed ID: 24579501
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
[TBL] [Abstract][Full Text] [Related]
26. Histopathologic characterization of hereditary benign prostatic hyperplasia.
Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
[TBL] [Abstract][Full Text] [Related]
27. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
[TBL] [Abstract][Full Text] [Related]
28. Age-related changes in guinea pig prostatic stroma.
Horsfall DJ; Mayne K; Ricciardelli C; Rao M; Skinner JM; Henderson DW; Marshall VR; Tilley WD
Lab Invest; 1994 May; 70(5):753-63. PubMed ID: 8196369
[TBL] [Abstract][Full Text] [Related]
29. Prostatitis in benign prostatic hyperplasia: a histological, bacteriological and clinical study.
Bedalov G; Vucković I; Fridrih S; Bruk M; Puskar D; Bartolin Z
Acta Med Croatica; 1994; 48(3):105-9. PubMed ID: 7532045
[TBL] [Abstract][Full Text] [Related]
30. [Association study between benign prostatic hyperplasia and primary hypertension].
Guo LJ; Zhang XH; Li PJ; Na YQ
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):108-11. PubMed ID: 15771818
[TBL] [Abstract][Full Text] [Related]
31. [Expression of Ki-67, Bcl-2,Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances].
Wang L; Yang JR; Yang LY; Liu ZT; Rao JM; Liu LF
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):222-6. PubMed ID: 18382056
[TBL] [Abstract][Full Text] [Related]
32. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Liu J; Li S; Shen W
Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
[TBL] [Abstract][Full Text] [Related]
33. Transurethral resection of the prostate (TURP)--in the treatment of benign prostatic hypertrophy (BPH) in Mekelle, Ethiopia.
Alemu MH
Ethiop Med J; 2009 Jan; 47(1):65-9. PubMed ID: 19743783
[TBL] [Abstract][Full Text] [Related]
34. [The incidences of benign prostatic hyperplasia and prostatic cancer in China].
Gu FL
Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844
[TBL] [Abstract][Full Text] [Related]
35. [A clinical analysis of benign prostatic hyperplasia with chronic prostatitis].
Wu XJ; Yang LY; Zhang XZ
Zhonghua Nan Ke Xue; 2008 Jun; 14(6):527-9. PubMed ID: 18649752
[TBL] [Abstract][Full Text] [Related]
36. Transrectal fine needle aspiration of prostate.
Jayaram G; Nakra N; Verma AK; Goel GD
J Assoc Physicians India; 1993 Jun; 41(6):364-6. PubMed ID: 7516326
[TBL] [Abstract][Full Text] [Related]
37. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?
Kramer G; Mitteregger D; Marberger M
Eur Urol; 2007 May; 51(5):1202-16. PubMed ID: 17182170
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical study of the expression of epidermal growth factor receptor in benign prostatic hypertrophy, prostatic intraepithelial neoplasia and prostatic carcinoma.
Rana S; Sen R; Kalra R; Arora B; Sharma P; Gahlawat S
Indian J Pathol Microbiol; 2006 Oct; 49(4):495-9. PubMed ID: 17183836
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic investigations of canine prostatitis incidence together with benign prostate hyperplasia, prostate malignancies, and biochemical recurrence in high-risk prostate cancer as a model for human study.
Shafiee R; Shariat A; Khalili S; Malayeri HZ; Mokarizadeh A; Anissian A; Ahmadi MR; Hosseini E; Naderafif M; Mohsenzadeh S; Rasoulian MH; Rezapour R; Pourzaer M
Tumour Biol; 2015 Apr; 36(4):2437-45. PubMed ID: 25420908
[TBL] [Abstract][Full Text] [Related]
40. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
